[Anti-GBM glomerulonephritis and RPGN].
Shimizu
Yoshio
Y
Tomino
Yasuhiko
Y
D000818:Animals; D001323:Autoantibodies; D003520:Cyclophosphamide / Q000008:administration & dosage; D018450:Disease Progression; D050533:Glomerular Basement Membrane / Q000276:immunology*; D005921:Glomerulonephritis / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007678:Kidney Glomerulus / Q000473:pathology / Q000648:ultrastructure; D008775:Methylprednisolone / Q000008:administration & dosage; D010951:Plasma Exchange; D011379:Prognosis; D020551:Pulse Therapy, Drug
D001323:Autoantibodies; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone